Dr. Jeffrey Smith named Executive Vice President and Chief Medical Officer Dr. John Fann promoted to Senior VP, Process Sciences Seven new Vice Presidents appointed, underscoring commitment to leadership development VANCOUVER, British Columbia, Jan. 04, 2024 (Korea Bizwire) – Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics [...]
WILMINGTON, Del., Jan. 03, 2024 (Korea Bizwire) – Enovis™ Corporation (NYSE: ENOV, “Enovis” or the “Company”) an innovation-driven, medical technology growth company, today announced that it closed the acquisition of LimaCorporate S.p.A. (“Lima”), a privately held global orthopedic leader focused on restoring motion through an innovative portfolio of implant solutions. Lima strengthens Enovis’ position in the global orthopedic reconstruction [...]
Foothill Ranch, Calif., Jan. 02 (Korea Bizwire) – Sweegen, the global leader in pioneering wellness ingredient and taste modulation technologies, announced a landmark victory in the U.S. Court of Appeals for the Federal Circuit, which has sided with Sweegen and affirmed the invalidation of PureCircle’s patents covering the highly sought-after stevia sweetener Rebaudioside M (Reb M). Sweegen is the [...]
SHANGHAI, China, Jan. 02, 2024 (Korea Bizwire) – Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the supplemental new drug application (the “sNDA”) for toripalimab (trade name: TUOYI®, product code: JS001) in combination with chemotherapy [...]
BOSTON, Dec. 30, 2023 (Korea Bizwire) – Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities, today released the latest 2023 global clinical trial landscape report on Metastatic Breast Cancer. The Novotech research analyst team provides these expert reports on a monthly basis, completely free of charge. These reports offer current insights into global [...]
BOSTON, Dec. 29, 2023 (Korea Bizwire) – Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities, today published the Navigating the Biotech Landscape whitepaper examining the significant financial shifts that affected the biotech industry in 2023. DOWNLOAD THE REPORT HERE The Novotech research analyst team offers these expert whitepapers at no cost to inform planning [...]
BOSTON, Dec. 28 (Korea Bizwire) – Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities, today released the latest 2023 global clinical trial landscape report on HIV, a condition now affecting more than 39 million people. The Novotech research analyst team provides these expert reports on a monthly basis, completely free of charge. These [...]
Proceeds expected to extend cash runway into H2 2027 VANCOUVER, British Columbia, Dec. 26, 2023 (Korea Bizwire) – Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biopharmaceutical company developing novel, multifunctional biotherapeutics, today announced that it had entered into a securities purchase agreement with funds affiliated with EcoR1 Capital, LLC (“EcoR1 Capital”), for the sale of an [...]
December 19, 2023 — Amsterdam, the Netherlands (Korea Bizwire) – Royal Philips (NYSE: PHG; AEX: PHIA) today announced that it has completed the cancellation of 15,134,054 of its shares. The cancelled shares were acquired as part of the EUR 1.5 billion share repurchase program for capital reduction purposes that was announced on July 26, 2021. Philips will complete [...]
ALBANY, N.Y., Dec. 15, 2023 (Korea Bizwire) – Curia, a leading contract research, development and manufacturing organization, today announced that Gerald Auer has been appointed as chief financial officer. He will join the organization effective Jan. 1, 2024. “I am delighted to welcome Gerald to Curia as we head into the new year,” said Curia [...]